ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

103

Target Audience Basic and translational researchers, clinicians Objectives

in global health or those seeking to expand their knowledge on the topic should be encouraged to attend. Objectives At the conclusion of this session, the participant will be able to: • describe major challenges to global lung health • define how local context affects the magnitude of the problem and effective solutions • define strategies for how global respiratory societies can work together to improve global lung health and decrease disparities An overarching principle of the American Thoracic Society is to improve global lung health and to serve as a resource for members from 129 countries with over 30% residing outside the United States. Common challenges face members in all countries although context matters. This symposium invites perspectives from peer respiratory societies to address the question, “What are the greatest global challenges to lung health?” 2:15 Opening Remarks 2:20 Equitable Access to Treatment and Health Care 2:37 Air Pollution

At the conclusion of this session, the participant will be able to: • learn how integrative anlaysis of multi-omic data sets, in this case, 16s sequencing and metabolite profiling can be integrated in lung disease- e.g. asthma and COPD • determine how, if you have a multi-omic data set and you have some microbe hits or metabolites that have been identified, to bring it to the next level mechanistically to see if your observations are worth pursuing therapuetically • gain an overview of the current methods needed to study small metabolites in the airspaces as well as specific pathogens correcting one pathogen at a time in chronic lung disease This session aims to offer a detailed and systematic understanding of the metabolic interaction between the host and microorganism within the airspaces of the lung. 2:15 The Interplay of Microbiome, Metabolism, and Immune Response in Asthma and COPD 2:33 Unveiling Active Microbial Metabolism through Functional Genomic Profiling of the Lower Airways 2:51 Harnessing Itaconate: Pseudomonas Aeruginosa’s Strategy of Redirecting Host-Derived Metabolite to Fuel Biofilm Formation 3:09 Metabolomic Profiles in Serum that Indicate Defects in Fatty Acid Oxidation Distinguish Subphenotypes of Acute Respiratory Distress Syndrome 3:27 Exploiting Host-Derived Metabolites as Weapons Against Antibiotic Resistance

2:54 Tobacco 3:11 Poverty 3:28 Panel Discussion

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

A93 CRITICAL CARE AND ACUTE CARE MEDICINE: DISPARITIES, QUALITY IMPROVEMENT, AND OUTCOMES 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 7A-B (Upper Level) Oral Presentations: 2:15 Significant Disparities Exist in Primary Care Provider Follow-up After Veterans Experience Sepsis 2:27 Area Deprivation Index and Likelihood of Presenting to ED With Sepsis 2:39 Examining the Association Between Hospital Environments and Intersectional Disparities in Mechanical Ventilation Outcomes

CLINICAL SCIENTIFIC SYMPOSIUM

A91 WHAT ARE THE GREATEST GLOBAL CHALLENGES TO LUNG HEALTH? Assembly on International Health Committee 2:15 p.m. - 3:45 p.m. San Diego Convention Center Room 29A-D (Upper Level) Target Audience Attendees from various backgrounds and levels of expertise can benefit from the discussion. All individuals with a general interest

ATS 2024 Conference Program • San Diego, CA